Aldeyra Stock Price Prediction

ALDX Stock  USD 4.85  0.04  0.83%   
At this time, The RSI of Aldeyra's share price is at 51. This suggests that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Aldeyra, making its price go up or down.

Oversold Vs Overbought

51

 
Oversold
 
Overbought
The successful prediction of Aldeyra's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Aldeyra, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Aldeyra's stock price prediction:
EPS Estimate Next Quarter
0.02
EPS Estimate Current Year
(0.90)
EPS Estimate Next Year
(0.43)
Wall Street Target Price
10
EPS Estimate Current Quarter
(0.25)
Using Aldeyra hype-based prediction, you can estimate the value of Aldeyra from the perspective of Aldeyra response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Aldeyra to buy its stock at a price that has no basis in reality. In that case, they are not buying Aldeyra because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Aldeyra after-hype prediction price

    
  USD 4.88  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Aldeyra Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Aldeyra Stock please use our How to Invest in Aldeyra guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aldeyra's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
2.536.3410.15
Details
Naive
Forecast
LowNextHigh
1.295.108.91
Details
8 Analysts
Consensus
LowTargetHigh
10.6211.6712.95
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.24-0.22-0.21
Details

Aldeyra After-Hype Price Prediction Density Analysis

As far as predicting the price of Aldeyra at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Aldeyra or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Aldeyra, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Aldeyra Estimiated After-Hype Price Volatility

In the context of predicting Aldeyra's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Aldeyra's historical news coverage. Aldeyra's after-hype downside and upside margins for the prediction period are 1.07 and 8.69, respectively. We have considered Aldeyra's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
4.85
4.88
After-hype Price
8.69
Upside
Aldeyra is slightly risky at this time. Analysis and calculation of next after-hype price of Aldeyra is based on 3 months time horizon.

Aldeyra Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Aldeyra is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aldeyra backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Aldeyra, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.10 
3.81
  0.03 
  0.02 
7 Events / Month
16 Events / Month
In about 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
4.85
4.88
0.62 
1,229  
Notes

Aldeyra Hype Timeline

Aldeyra is presently traded for 4.85. The entity has historical hype elasticity of 0.03, and average elasticity to hype of competition of 0.02. Aldeyra is forecasted to increase in value after the next headline, with the price projected to jump to 4.88 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.62%, whereas the daily expected return is presently at -0.1%. The volatility of related hype on Aldeyra is about 2145.04%, with the expected price after the next announcement by competition of 4.87. Net Loss for the year was (37.54 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next forecasted press release will be in about 7 days.
Check out Aldeyra Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Aldeyra Stock please use our How to Invest in Aldeyra guide.

Aldeyra Related Hype Analysis

Having access to credible news sources related to Aldeyra's direct competition is more important than ever and may enhance your ability to predict Aldeyra's future price movements. Getting to know how Aldeyra's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Aldeyra may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
TARSTarsus Pharmaceuticals(1.03)10 per month 1.79  0.25  8.19 (3.85) 16.85 
LIANLianBio ADR 0.00 0 per month 3.34  0.01  6.76 (5.00) 20.98 
TVTXTravere Therapeutics(0.38)8 per month 1.92  0.25  11.58 (4.13) 23.97 
ETONEton Pharmaceuticals 0.22 10 per month 1.77  0.36  7.56 (3.13) 21.89 
VRDNViridian Therapeutics 0.52 11 per month 3.45  0.07  6.84 (5.29) 44.89 
TERNTerns Pharmaceuticals(0.11)11 per month 0.00 (0.09) 5.68 (5.96) 34.09 
GPCRStructure Therapeutics American 0.40 10 per month 0.00 (0.07) 8.18 (6.07) 24.50 
BPMCBlueprint Medicines Corp 3.17 10 per month 2.61 (0.03) 4.90 (3.62) 14.28 
ETNB89bio Inc(0.11)9 per month 3.29  0.0002  5.19 (6.35) 27.43 
XFORX4 Pharmaceuticals 0.02 7 per month 0.00 (0.08) 6.90 (10.61) 62.35 
INZYInozyme Pharma(0.16)8 per month 0.00 (0.27) 5.68 (7.92) 16.62 
DAWNDay One Biopharmaceuticals 0.23 9 per month 2.72 (0.04) 3.84 (3.69) 11.44 
HOOKHookipa Pharma 0.09 7 per month 0.00 (0.36) 4.05 (7.24) 22.98 
PHATPhathom Pharmaceuticals(0.98)9 per month 0.00 (0.07) 8.25 (6.83) 40.10 
LYRALyra Therapeutics 0.01 4 per month 0.00 (0.10) 8.00 (10.00) 41.07 
CGEMCullinan Oncology LLC 1.25 10 per month 0.00 (0.17) 5.88 (7.24) 17.85 
BLRXBioLineRx(0.02)3 per month 0.00 (0.19) 4.88 (9.80) 59.21 
ARDXArdelyx 0.62 12 per month 0.00 (0.05) 4.96 (6.13) 33.99 
LXRXLexicon Pharmaceuticals 0.01 9 per month 0.00 (0.17) 6.70 (7.55) 46.58 
MCRBSeres Therapeutics(0.06)9 per month 5.68 (0.02) 10.00 (9.78) 28.84 
IBRXImmunitybio 0.04 8 per month 4.45  0.06  13.00 (7.80) 35.54 

Aldeyra Additional Predictive Modules

Most predictive techniques to examine Aldeyra price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aldeyra using various technical indicators. When you analyze Aldeyra charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Aldeyra Predictive Indicators

The successful prediction of Aldeyra stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Aldeyra, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Aldeyra based on analysis of Aldeyra hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Aldeyra's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aldeyra's related companies.

Story Coverage note for Aldeyra

The number of cover stories for Aldeyra depends on current market conditions and Aldeyra's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aldeyra is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aldeyra's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Aldeyra Short Properties

Aldeyra's future price predictability will typically decrease when Aldeyra's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Aldeyra often depends not only on the future outlook of the potential Aldeyra's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aldeyra's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding58.9 M
Cash And Short Term Investments142.8 M

Additional Tools for Aldeyra Stock Analysis

When running Aldeyra's price analysis, check to measure Aldeyra's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aldeyra is operating at the current time. Most of Aldeyra's value examination focuses on studying past and present price action to predict the probability of Aldeyra's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aldeyra's price. Additionally, you may evaluate how the addition of Aldeyra to your portfolios can decrease your overall portfolio volatility.